These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7727540)

  • 61. Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue.
    Schumann M; Richter JF; Wedell I; Moos V; Zimmermann-Kordmann M; Schneider T; Daum S; Zeitz M; Fromm M; Schulzke JD
    Gut; 2008 Jun; 57(6):747-54. PubMed ID: 18305066
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.
    Devery JM; La Brooy JT; Krillis S; Davidson G; Skerritt JH
    Clin Exp Immunol; 1989 Jun; 76(3):384-90. PubMed ID: 2752594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protective effects of ID331 Triticum monococcum gliadin on in vitro models of the intestinal epithelium.
    Iacomino G; Di Stasio L; Fierro O; Picariello G; Venezia A; Gazza L; Ferranti P; Mamone G
    Food Chem; 2016 Dec; 212():537-42. PubMed ID: 27374565
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A role for tissue transglutaminase in alpha-gliadin peptide cytotoxicity.
    Sakly W; Thomas V; Quash G; El Alaoui S
    Clin Exp Immunol; 2006 Dec; 146(3):550-8. PubMed ID: 17100777
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Purification and partial sequence of an alpha 3-gliadin.
    Turner JB; Garner GV; Gordon DB; Smith CA
    Biochem Soc Trans; 1995 Nov; 23(4):632S. PubMed ID: 8654817
    [No Abstract]   [Full Text] [Related]  

  • 66. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
    Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
    Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coeliac active peptides from gliadin: large-scale preparation and characterization.
    Wieser H; Belitz HD
    Z Lebensm Unters Forsch; 1992 Mar; 194(3):229-34. PubMed ID: 1519388
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone in celiac intestinal mucosa.
    Colombo G; Buffa R; Bardella MT; Garofalo L; Carlin A; Lipton JM; Catania A
    Neuroimmunomodulation; 2002-2003; 10(4):208-16. PubMed ID: 12584408
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Deficient activity of mammalian prolyl oligopeptidase on the immunoactive peptide digestion in coeliac disease.
    Garcia-Horsman JA; Venäläinen JI; Lohi O; Auriola IS; Korponay-Szabo IR; Kaukinen K; Mäki M; Männistö PT
    Scand J Gastroenterol; 2007 May; 42(5):562-71. PubMed ID: 17454876
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease.
    Kagnoff MF; Paterson YJ; Kumar PJ; Kasarda DD; Carbone FR; Unsworth DJ; Austin RK
    Gut; 1987 Aug; 28(8):995-1001. PubMed ID: 2822550
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gliadin-dependent cytokine production in a bidimensional cellular model of celiac intestinal mucosa.
    Vincentini O; Maialetti F; Gonnelli E; Silano M
    Clin Exp Med; 2015 Nov; 15(4):447-54. PubMed ID: 25447031
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coeliac disease: A review of the causative agents and their possible mechanisms of action.
    Cornell HJ
    Amino Acids; 1996 Mar; 10(1):1-19. PubMed ID: 24178429
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Partial in vitro digestion of active gliadin-related peptides in celiac disease.
    Cornell HJ
    J Protein Chem; 1998 Nov; 17(8):739-44. PubMed ID: 9988520
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The activity of wheat gliadin peptides in in vitro assays for coeliac disease.
    Cornell HJ; Mothes T
    Biochim Biophys Acta; 1993 Apr; 1181(2):169-73. PubMed ID: 8481406
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells.
    De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V
    Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationship between gliadin peptide structure and their effect on the fetal chick duodenum.
    Kocna P; Mothes T; Krchnák V; Fric P
    Z Lebensm Unters Forsch; 1991 Feb; 192(2):116-9. PubMed ID: 2014713
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gliadin, glutenin or both? The search for the Holy Grail in coeliac disease.
    Howdle PD
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):703-6. PubMed ID: 16772825
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Further studies of the in vitro activity of synthetic gliadin peptides in coeliac disease.
    Cornell H; Mothes T
    Biochim Biophys Acta; 1995 Apr; 1270(2-3):168-72. PubMed ID: 7727540
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.